Market potential Target hospitals and long-term care facilities seeking innovative catheter solutions that reduce infections and improve patient comfort, leveraging the TrueClr line announced in 2022 to position Ur24Technology as a value-driven partner in infection control and patient quality of life.

Clinical impact Highlight the potential to lower catheter-associated urinary tract infections and related costs, presenting a compelling ROI case to procurement and clinical teams at mid to large healthcare systems.

Startup agility With a lean team and recent product launch, emphasize quick deployment, clinical training, and dedicated customer support as differentiators for hospitals seeking flexible partnerships and faster time-to-value.

Digital funnel Leverage existing tech stack (Shopify, Facebook Pixel, Google Tag Manager) to optimize digital outreach, track engagement, and retarget clinicians and purchasing decision-makers with educational content and case studies.

Strategic partnerships Position Ur24Technology as a collaboration-ready supplier for large systems and distributors, leveraging similarities to major B2B tech players in workforce scale to engage enterprise accounts and channel partners despite a small internal footprint.